The of logic of ‘Highly appealing to Shareholsers’ is pretty flawed. How many people seriously bought under 32c? Only 6 months ago it was 60c.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%